Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25463546 | 0.92 | ALOX15 (0.51) | SMN1; SMN2CYP1A2CYP19A1MEN1KMT2A | |
| SCHEMBL26467679 | 0.89 | CYP19A1 (0.45) | SMN1; SMN2CYP19A1MEN1KMT2AALOX15 | |
| SCHEMBL21296900 | 0.85 | CYP19A1 (0.57) | SMN1; SMN2CYP19A1MEN1KMT2AALOX15 | |
| SCHEMBL22815777 | 0.83 | ALOX15 (0.47) | SMN1; SMN2CYP1A2MEN1KMT2AALOX15 | |
| SCHEMBL26467692 | 0.82 | CYP19A1 (0.46) | SMN1; SMN2CYP1A2CYP19A1MEN1KMT2A | |
| SCHEMBL21296928 | 0.82 | ALOX15 (0.49) | SMN1; SMN2CYP1A2CYP19A1MEN1KMT2A | |
| SCHEMBL26467846 | 0.82 | ALOX15 (0.49) | CYP19A1MEN1KMT2AALOX15L3MBTL1 | |
| SCHEMBL23319902 | 0.81 | MEN1 (0.60) | SMN1; SMN2CYP1A2MEN1KMT2AALOX15 | |
| SCHEMBL18321160 | 0.81 | CYP1A2 (0.55) | SMN1; SMN2CYP1A2CYP19A1MEN1KMT2A | |
| SCHEMBL26467810 | 0.79 | CYP19A1 (0.39) | SMN1; SMN2CYP1A2CYP19A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230129160-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230129160-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | TH, AOX1, AOC3 | SMN1; SMN2 4112/4885CYP1A2 62/4885CYP19A1 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.